Apyx Medical Corp reports results for the quarter ended in December - Earnings Summary

Apyx Medical

16/03/2023 13:31

* Apyx Medical Corp  APYX.OQ  reported a quarterly adjusted
loss
of 17 cents​​ per share for the quarter ended in December. The
mean expectation of four analysts for the quarter was for a loss
of 14 cents per share.
    * Revenue fell 25% to $12.61 million from a year ago;
analysts
expected $12.94 million. 
    * Apyx Medical Corp's reported EPS for the quarter was a
loss
of 17 cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Apyx Medical Corp shares had risen by 12.0% this quarter.
    * The company reported a quarterly loss of $6.05 million.
    * Wall Street's median 12-month price target for Apyx
Medical Corp
is $7.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 16 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.14          -0.17          Missed
 Sep. 30 2022      -0.14          -0.17          Missed
 Jun. 30 2022      -0.19          -0.16          Beat
 Mar. 31 2022      -0.15          -0.17          Missed